Sort
3,198 grants matching “mrna vaccine”
Autoimmunity: Mechanisms of Unresponsiveness
$1,002,938Charles Garrison Fathman · Stanford University · P01 · FY2007 · AI
Autoimmunity: Mechanisms of Unresponsiveness
$1,002,489Stanford University · P01 · FY2005 · AI
SARS-CoV-2 vaccines based on RBDs with engineered glycosylation sites
$1,000,000Michael David Alpert · Emmune, Inc · R44 · FY2023 · AI
GMP production and GLP safety of bidirectionally targeted SARS-CoV-2 booster vaccine
$1,000,000Ellen Elizabeth Sparger · Tendel Therapies Inc. · R44 · FY2023 · AI
Hepatoselective Dihydrozuinolizone (HS-DHQ) Molecules for Treatment and Prevention of Hepatitis A Virus (HAV) Infection
$1,000,000Yanming Du · Harlingene Life Sciences Llc · R42 · FY2025 · AI
SARS-CoV-2 vaccines based on RBDs with engineered glycosylation sites
$1,000,000Michael David Alpert · Emmune, Inc · R44 · FY2024 · AI
SARS-CoV-2 vaccines based on RBDs with engineered glycosylation sites
$1,000,000Michael David Alpert · Emmune, Inc · R44 · FY2025 · AI
Beginnings: Diversifying Talent in Advanced Biologics Manufacturing
$999,691Baley Reeves · Texas A&M Engineering Experiment Station · · FY2024 · TIP
mRNA-based chimeric membrane protein vaccination strategies directed at the MPER
$993,881Mikyung Kim · Dana-Farber Cancer Inst · P01 · FY2025 · AI
Clinic-Ready MACH-1 Gene Gun for delivery of a universal influenza DNA vaccine
$990,275Hannah Frizzell · Orlance, Inc. · R44 · FY2024 · AI
Role of Viral Reservoirs in the Pathogenesis of HIV Disease
$990,110Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Development of three KSHV vaccine platforms and chimeric MHV68-K-G for in vivo mouse infection study
$989,903Jae U Jung · Cleveland Clinic Lerner Com-Cwru · U01 · FY2024 · CA
Epitranscriptomic regulation in the mammalian nervous system
$985,026Guo-Li Ming · University Of Pennsylvania · R35 · FY2025 · NS
The longevity and nature of the anti-SARS-CoV-2 cellular and humoral immune responses
$983,100Michel C Nussenzweig · Rockefeller University · P01 · FY2023 · AI
Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine
$981,917Amit Praful Khandhar · Hdt Bio Corporation · R33 · FY2024 · AI
Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine
$981,683Amit Praful Khandhar · Hdt Bio Corporation · R33 · FY2025 · AI
Host Immune Responses to Antigens of Malaria Parasites
$980,178Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
SBIR Phase II: High-capacity membrane for fast and selective capture of mRNA
$977,854Graham Temples · Purilogics, Llc · R44 · FY2021 · GM
Clinic-Ready MACH-1 Gene Gun for delivery of a universal influenza DNA vaccine
$977,255Hannah Frizzell · Orlance, Inc. · R44 · FY2025 · AI
Eliciting neutralizing antibodies and B cell responses using novel HIV Env immunogens in non-human primates
$976,445Richard Thomas Wyatt · Scripps Research Institute, The · P01 · FY2024 · AI
Autoimmunity: Mechanisms of Unresponsiveness
$973,295Stanford University · P01 · FY2004 · AI
Development of three KSHV vaccine platforms and chimeric MHV68-K-G for in vivo mouse infection study
$972,133Jae U Jung · Cleveland Clinic Lerner Com-Cwru · U01 · FY2025 · CA
Virus-Host Interactions: Induction and Evasion of Host Innate Immunity
$970,517Sonja Best · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
RNA: New Antimicrobial Strategies
$969,159Adrian Ferrã-D'amarã · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Novel Targets for Vaccine Therapy
$962,130Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA